A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori (Q82831287)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21147129 AND SRC:MED&resulttype=core&format=json

18 January 2020

title

A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21147129 AND SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Helicobacter pylori infectious disease

1 reference

Carl-Fredrik Flach

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21147129 AND SRC:MED&resulttype=core&format=json

18 January 2020

Natascha Svensson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21147129 AND SRC:MED&resulttype=core&format=json

18 January 2020

Margareta Blomquist

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21147129 AND SRC:MED&resulttype=core&format=json

18 January 2020

Annelie Ekman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21147129 AND SRC:MED&resulttype=core&format=json

18 January 2020

Sukanya Raghavan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21147129 AND SRC:MED&resulttype=core&format=json

18 January 2020

Jan Holmgren

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21147129 AND SRC:MED&resulttype=core&format=json

18 January 2020

publication date

13 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21147129 AND SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21147129 AND SRC:MED&resulttype=core&format=json

18 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21147129 AND SRC:MED&resulttype=core&format=json

18 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21147129 AND SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

1235-1241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21147129 AND SRC:MED&resulttype=core&format=json

Pathogenesis of Helicobacter pylori infection

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Helicobacter pylori infection and the pathogenesis of gastric cancer: a paradigm for host-bacterial interactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Helicobacter pylori recurrence in developed and developing countries: meta-analysis of 13C-urea breath test follow-up after eradication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

HpaA shows variable surface localization but the gene expression is similar in different Helicobacter pylori strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

The putative neuraminyllactose-binding hemagglutinin HpaA of Helicobacter pylori CCUG 17874 is a lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Frequencies of the expression of main protein antigens from Helicobacter pylori isolates and production of specific serum antibodies in infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

The complete genome sequence of the gastric pathogen Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

HpaA is essential for Helicobacter pylori colonization in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Absence of CD4 CD25 regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

A H -gated urea channel: the link between Helicobacter pylori urease and gastric colonization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Sublingual vaccination with influenza virus protects mice against lethal viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Recombinant HpaA purified from Escherichia coli has biological properties similar to those of native Helicobacter pylori HpaA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

The current status of Helicobacter pylori vaccines: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Proinflammatory Cytokine Gene Expression in the Stomach Correlates with Vaccine-Induced Protection against Helicobacter pylori Infection in Mice: an Important Role for Interleukin-17 during the Effector Phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Sublingual immunization induces broad-based systemic and mucosal immune responses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

CCR7-CCL19/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Comparison of different routes of vaccination for eliciting antibody responses in the human stomach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

inferred from DOI database lookup

7 January 2021

based on heuristic

Catalase, a novel antigen for Helicobacter pylori vaccination

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.11.088

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2010.11.088

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21147129 AND SRC:MED&resulttype=core&format=json

18 January 2020

1 reference